fetching data ...
version:
1.02
Home
Search:
Free Text Search
List:
Abstract Titles
Sessions
Authors
Keywords
Bookmarks
Include in search:
all years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
List: Sessions
Go!
Years:
2025 (Barcelona, Spain)
Total Number of items found:
167
in
17
pages.
Goto page:
10
50
100
Jump to page containing Sessions starting with :
A
B
C
D
E
H
I
J
L
M
N
O
P
R
S
T
U
V
W
Sessions
[1]
A tasty DISH: Diffuse idiopathic skeletal hyperostosis for the rheumatologist
2025
2025 OP0241
INFLUENCE OF OBESITY ON THE RADIOGRAPHIC DAMAGE IN PATIENTS WITH DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS
,
D. Kiefer, G. Michail, U. Kiltz, P. Sewerin, S. Tsiami, I. Andreica, I. Redeker, X. Baraliakos
[2]
AI in medicine: Your future doctor and researcher
2025
2025 OP0363-PARE
Co-Design in Action: Mobilising knowledge and lived experience to design D-MAPP, a digital self-management intervention for distal upper limb MSDs
,
L. Brading, J. Rimmer, S. Mason, S. Kingsbury, P. G. Conaghan, I. Kellar
2025 OP0364-PARE
Leveraging machine learning to identify predictors of digital health technologies among rheumatic patients using German nationwide survey data
,
F. Muehlensiepen, P. Petit, S. May, N. Vuillerme
[8]
Abstract Plenary
2025
2025 OP0001
COMPARATIVE ANALYSIS OF SYNOVIAL TISSUE TOPOGRAPHY BY SINGLE CELL TRANSCRIPTOMICS AND SPATIAL TRANSCRIPTOMICS REVEALS DISCRETE AND OVERLAPPING DISEASE PATHWAYS DRIVING CHECKPOINT INHIBITOR-INDUCED AND SPONTANEOUS INFLAMMATORY ARTHRITIS
,
J. D. Turner, A. K. McLean, A. Thomson, K. Williams, I. Nicorescu, L. Jones, G. Merces, A. Teodosio, B. Hunter, J. McMurray, S. Gilbert, A. Degnan, D. Scheel-Toellner, S. Jariwala, Q. An, R. Plummer, A. P. Croft, L. Pallan, B. A. Fisher, J. Coxhead, R. Hussain, M. Magid-Slav, D. McDonald, S. Siebert, A. Filby, G. Reynolds, A. E. Anderson, C. Hilkens, D. F. Tough, A. Filer, A. Pratt
2025 OP0002
EFFICACY AND SAFETY OF EFGARTIGIMOD PH20 SC IN ADULT PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY: PHASE 2 RESULTS FROM THE ALKIVIA STUDY
,
H. Chinoy, S. Rodriguez-Garcia, A. Neto, D. Papadopoulou, B. Van Baelen, P. Duncombe, L. De Ceuninck, B. van der Woning, R. Aggarwal
2025 OP0003
CAN VASOACTIVE VASODILATING DRUGS INFLUENCE PROGRESSION AND PROGNOSIS OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE A EUSTAR COHORT STUDY
,
A. C. Sarbu, L. Petelytska, L. Tofani, G. Moroncini, A. Balbir-Gurman, E. Zanatta, J. Henes, P. Airò, M. Matucci-Cerinic, A. M. Gheorghiu, A. Marcoccia, B. Anic, J. Colic, D. Furst, J. Spierings, B. Maurer, A. M. Hoffmann-Vold, O. Distler, D. C. Bruni
2025 OP0004
ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRE-CLINICAL PHASE OF RA WITH ABATACEPT LONG TERM OUTCOMES (ALTO) STUDY
,
A. Cope, M. Jasenecova, J. Vasconcelos, A. Filer, K. Raza, S. Qureshi, M. A. D’Agostino, I. B. McInnes, S. Siebert, J. Isaacs, A. Pratt, B. A. Fisher, C. D. Buckley, P. Emery, K. Mankia, P. Ho, M. Buch, C. Ciurtin, D. van Schaardenburg, T. Huizinga, R. E. M. Toes, C. Murphy, A. T. Prevost
2025 OP0005
CARDIOVASCULAR OUTCOMES OF TREAT-TO-TARGET VERSUS FIRE-AND-FORGET URATE-LOWERING TREATMENT IN GOUT: EMULATED TARGET TRIAL STUDIES USING LINKED ENGLISH AND SWEDISH PRIMARY CARE, HOSPITALISATION AND MORTALITY DATA
,
E. Cipolletta, T. Zverkova Sandstrom, D. Rozza, C. Leyrat, G. Nakafero, P. Drivelegka, A. Avery, M. Mamas, L. Tata, M. Dehlin, A. Abhishek
2025 OP0006
OBINUTUZUMAB DEMONSTRATES CONSISTENT BENEFIT ACROSS NUMEROUS PRIMARY ENDPOINT DEFINITIONS USING REGENCY STUDY RESULTS OF PATIENTS WITH ACTIVE LUPUS NEPHRITIS
,
B. H. Rovin, W. F.III Pendergraft, L. Lightstone, Z. Amoura, R. A. Furie, I. Hassan, B. Yoo, E. Martins, A. C. Hans, T. A. Omachi, T. Schindler, J. Garg, J. Henes, A. Malvar
2025 OP0007-HPR
EFFECTIVENESS AND COST-UTILITY OF A MULTIMODAL, PHYSIOTHERAPIST-LED, VOCATIONAL INTERVENTION FOR PEOPLE WITH RHEUMATOID ARTHRITIS OR AXIAL SPONDYLOARTHRITIS AND A REDUCED WORK ABILITY: A RANDOMIZED, CONTROLLED TRIAL
,
N. Bakker, J. Knoop, W. B. van den Hout, N. Hutting, J. Engels, J. B. Staal, M. van der Leeden, A. Boonen, A. Willemze, M. Nurmohamed, M. G. J. Gademan, T. P. M. Vliet Vlieland, S. van Weely
2025 OP0008-PARE
HARNESSING THE CREATIVITY OF TEENS AND YOUNG ADULTS: SUSTAINING AN INITIATIVE TO EMPOWER NEW PATIENT RESEARCH PARTNERS
,
K. Carandang, E. Chintagunta, A. Khurana, J. Ziegler, C. Wells
[51]
Across diseases
2025
2025 ABS0002
LONG-TERM PLATELET P-SELECTIN PREDICTIVE ROLE FOR THROMBOSIS IN CONNECTIVE TISSUE DISEASES AND SYSTEMIC VASCULITIS
,
G. A. Ramirez, E. Allegrini, C. Campochiaro, L. Moroni, A. Tomelleri, E. Baldissera, G. De Luca, M. Matucci-Cerinic, L. Dagna, A. Manfredi, N. Maugeri
2025 ABS0034
APPLICATION OF CLUSTERING TECHNIQUES FOR PATIENT STRATIFICATION IN RHEUMATIC DISEASES
,
A. García-Alija, B. P. Magallares, H. S. Park, G. Verdaguer, A. Laiz, P. Moya, A. Casals Urquiza, C. Díaz-Torné, L. Sainz Comas, I. Castellví, S. P. Fernandez-Sanchez, J. Bernardez, H. Codes, J. L. Tandaipan, C. Pitarch, C. Marco Pascual, A. Garcia Guillen, N. Fernández-Verdés, L. Úbeda, M. À. Melchor, M. Sihuro, S. Ros, H. Corominas
2025 ABS0041
BODY MASS INDEX AND RHEUMATIC JOINT DISORDERS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF MENDELIAN RANDOMIZATION STUDIES
,
T. Fatima, F. Nord, C. Maglio
2025 ABS0046
THE EVOLVING ROLE OF JANUS KINASE INHIBITORS (JAKI) IN RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMDS): AN INTERNATIONAL DELPHI STUDY
,
A. Barkaway, P. J. Mease, R. Moots, M. Ndosi, Z. Rutter-Locher, M. McLean
2025 ABS0047
MATERNAL AND NEONATAL ANTI-RO52, ANTI-RO60 AND ANTI-LA LEVELS CORRELATE WITH INTERFERON SCORES
,
L. Rudolph, M. Hedlund, E. Richardsdotter Andersson, V. Ottosson, J. Tingström, F. Nordenstam, G. Bergman, S. E. Sonesson, G. E. Thorlacius, M. Wahren-Herlenius
2025 ABS0091
Real-world incidence of VTE in Rheumatology patients- are we seeing any signal realted to JAKi use Data from a 6.5 year retrospective analysis.
,
G. Dulay, C. Beevor, L. Goh
2025 ABS0101
Exploring Biomarkers Across Rheumatic and Musculoskeletal Diseases Using Machine Learning on Deep Immunophenotyping and Serum Proteomics
,
K. Matsumoto, M. Takeshita, K. Suzuki, Y. Kaneko
2025 ABS0163
PREDICTION OF RHEUMATOLOGICAL DISEASES USING MACHINE LEARNING MODELS AND NATURAL LANGUAGE PROCESSING TECHNIQUES ON PHYSICIAN NOTES
,
A. C. Genç, F. Turkoglu, E. Bilgin, E. Gönüllü
2025 ABS0200
KT501, A CD19, BCMA-DIRECTED T-CELL ENGAGER (TCE), LEADS TO DEEP B-CELL DEPLETION AND MINIMAL CYTOKINE RELEASE IN VIVO
,
J. Wang
2025 ABS0266
PREVALENCE, DEMOGRAPHIC ASSOCIATIONS, AND CLINICAL IMPLICATIONS OF ANTI-C1q ANTIBODY ELEVATIONS ACROSS DIVERSE DISEASE STATES
,
Y. Liang, S. Xie, W. Zhu, Q. Guo, B. Zheng, C. Lu, Y. Jiang
2025 ABS0280
UNVEILING SYNERGISTIC DRUG COMBINATIONS FOR IMMUNE-MEDIATED INFLAMMATORY DISEASES: INSIGHTS FROM THE DoCTIS CONSORTIUM USING SYSTEMS BIOLOGY APPROACHES
,
A. Julià, E. Choy, M. A. López Lasanta, P. Vela Casasempere, A. Fernández Nebro, S. Castañeda, C. Marras, J. Calvo Alén, J. Tornero Molina, J. D. D. Cañete Crespillo, E. Domènech, J. P. Gisbert, J. M. Carrascosa, E. Fonseca, L. Bujanda Fernández de Pierola, V. García Sánchez, B. Siegmund, G. Girolomoni, H. Heyn, L. Jimenez, P. Santamaría, E. Angelats, R. Myers, Y. Guillén, S. H. Martínez-Mateu, S. Marsal
2025 ABS0364
SAFETY AND EFFICACY OF T CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE
,
L. Bucci, S. Boeltz, M. Hagen, D. M. Nöthling, T. Rothe, C. Tur, A. Wirsching, J. Auth, J. Wacker, M. Eckstein, S. Alivernini, A. Bozec, C. Bergmann, M. A. D’Agostino, M. G. Raimondo, G. Schett, R. Grieshaber-Bouyer
2025 ABS0375
ONE POINT IN TIME ASSESSMENTS OF SYSTEMIC INFLAMMATION MARKERS AND DISEASE ACTIVITY SCORES IN 28 JOINTS ARE USEFUL IN IDENTIFYING HIGH RISK ATHEROSCLEROSIS IN PATIENTS WITH FIBROMYALGIA BUT NOT RHEUMATOID ARTHRITIS OR OSTEOARTHRITIS
,
N. Dlongolo, G. Tade, M. Seboka, A. Solomon, G. Teckie, H. C. Hsu, P. Dessein
2025 ABS0380
SCORE2 IS MORE USEFUL THAN THE FRAMINGHAM SCORE IN IDENTIFYING HIGH RISK ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS, OSTEOARTHRITIS AND FIBROMYALGIA
,
G. Tade, N. Dlongolo, M. Seboka, A. Woodiwiss, U. Mariani, M. Dzikinu, P. Dessein
2025 ABS0408
HYPERURICEMIA AS CARDIOVASCULAR RISK FACTOR: A STUDY IN PATIENTS WITH RHEUMATIC DISEASES
,
A. Mayo-Juanatey, J. Lacasa-Molina, M. Robustillo-Villarino, L. Montolio-Chiva, C. Valera-Ribera, P. A. Mencio-Viana, P. León-Torralba, P. Andújar-Brazal, A. Taberner-Cortés, I. Vázquez-Gómez, E. Valls-Pascual, À. Martínez-Ferrer, D. Ybáñez-García, J. J. Alegre Sancho
2025 ABS0413
LET’S ASK THE PATIENT: DISEASE PREDICTION BASED ON FREE-TEXT SYMPTOM DESCRIPTIONS
,
I. Pérez - Sancristóbal, N. Steinz, L. Qin, T. D. Maarseveen, F. Zegers, B. Bislawska Axnäs, L. Rodriguez Rodriguez, R. Knevel
2025 ABS0449
EFFECTIVENESS AND TOLERABILITY OF INTERLEUKIN-6 INHIBITORS IN THE TREATMENT OF SYSTEMIC AUTOIMMUNE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASES
,
A. Dupont, R. Borie, C. Dupin, E. Ebstein, S. Ottaviani, M. Forien, P. Leguen, Q. Philippot, B. Crestani, P. Dieudé, P. A. Juge
2025 ABS0473
SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A FIRST OBSERVATIONAL STUDY IN RHEUMATIC DISEASE
,
O. Fogel, C. Bottois, M. L. Tourneur, A. Dauchez, R. D’Alessandro, V. Gaud-Listrat, C. Goulvestre, K. Habhab, C. Souffir, C. Miceli Richard, A. Moltó, J. Avouac, Y. Allanore
2025 ABS0493
POSITIVE ANXIETY, DEPRESSION AND/OR FIBROMYALGIA MDHAQ SCREENING IS SEEN IN 30-50% OF ROUTINE CARE PATIENTS WITH ALL RHEUMATIC DIAGNOSES
,
J. Schmukler, T. Li, T. Pincus
2025 ABS0541
DOES THE HUMAN MICROBIOTA INTERACT WITH IMMUNOSUPPRESSIVE TREATMENT OF SYSTEMIC AUTOIMMUNE RHEUMATOLOGICAL DISEASES A SYSTEMATIC REVIEW
,
N. Franco Domingo, P. Saiz López, L. Carmona
2025 ABS0555
SAFETY PROFILE OF SUBCUTANEOUS EFGARTIGIMOD PH20 FROM CLINICAL TRIALS IN MYASTHENIA GRAVIS AND CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
,
P. A. van Doorn, T. Skripuletz, K. Gwathmey, J. De Bleecker, J. F.Jr. Howard, T. Vu, J. A. Allen, S. Agha, M. Jiang, W. Reiss, P. Ulrichts, J. Guptill, J. Podhorna, L. Liu, R. A. Lewis
2025 ABS0576
Safety and effectiveness of the use of combined therapy with bDMARDS and tsDMARDs in inmune-mediated inflammatory diseases
,
N. López-Juanes, C. Ureta, M. Novella-Navarro, I. Monjo-Henry, D. Peiteado, A. Villalba, L. Nuño, M. Sanz-Jardon, M. Á. González-Fernández, C. Suárez, A. Remesal, R. Alcobendas, C. Udaondo, E. Sendagorta, V. Navarro-Compán, A. Balsa, E. De Miguel, C. Plasencia-Rodríguez
2025 ABS0597
CHILDHOOD TONSILLECTOMY IS ASSOCIATED WITH INCREASED RISK OF AUTOIMMUNE DISEASES: A NATIONWIDE POPULATION-BASED STUDY IN KOREA
,
H. Jeong, E. J. Park, C. H. Jeon, Y. S. Chang
2025 ABS0601
PERCEPTIONS AND EXPECTATIONS: HOW GERMAN RHEUMATOLOGISTS VIEW EMERGING T-CELL REDIRECTING THERAPIES
,
A. Meinecke, J. Knitza, T. Witte, J. Rademacher, F. Mueller, C. Duesing, M. Zeeck, R. Grieshaber-Bouyer, M. Hagen, I. Haase, M. T. Holzer
2025 ABS0641
THE PATIENT JOURNEY IN RHEUMATIC AND MUSCULOSKELETAL DISORDERS: A SYSTEMATIC REVIEW
,
T. Oton, M. Villalobos Quesada, E. Loza, L. Carmona
2025 ABS0669
IMPACT OF WEIGHT STATUS ON HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENTS WITH RHEUMATIC CONDITIONS: A STUDY OF SPANISH AND ENGLISH-SPEAKING COHORTS
,
A. Freeman, O. Harry
2025 ABS0693
IDENTIFYING STEREOTYPES AMONGST EARLY TRAINEES FOR PATIENTS WITH RHEUMATIC DISEASES
,
K. Young, L. Hamilton, J. Liew, J. Stone
2025 ABS0695
SEX DIFFERENCES ASSOCIATED WITH OVERALL TOLERANCE AFTER A SWITCH TO AN ADALIMUMAB BIOSIMILAR, A POST-HOC ANALYSIS FROM THE YU-MATTER STUDY
,
H. Marotte, G. Bouguen, A. Dellal, L. Foulley, C. Habauzit, S. Benkhalifa, L. Gossec
2025 ABS0745
Characterization and differentiation of preclinical rheumatoid arthritis vs. psoriatic arthritis by clinical and imaging parameters and their potential role in the prediction of arthritis development
,
N. Nendel, J. Klotsche, G. Schmittat, M. Backhaus, G. Krönke, G. R. Burmester, G. Kokolakis, S. Ohrndorf
2025 ABS0746
Predicting interstitial lung disease severity in patients with connective tissue diseases: The role of clinical parameters and artificial intelligence quantified pulmonary high-resolution computed tomography
,
T. Hoffmann, U. Teichgräber, B. Lassen-Schmidt, D. Renz, L. B. Brüheim, M. Krämer, J. Böttcher, F. Güttler, G. Wolf, A. Pfeil
2025 ABS0752
Fatigue across 12 inflammatory rheumatic diseases: long-term patient documentation from the National database of the German Collaborative Arthritis Centres from 2007 to 2023
,
K. Thiele, K. Albrecht, J. Callhoff, K. Karberg, B. Köhler, J. Richter
2025 ABS0829
THE RISE OF RHEUMATIC AND MUSCULOSKELETAL TELEREHABILITATION INTERVENTIONS AND FALL OF THEORETICAL GROUNDING: A SCOPING REVIEW
,
P. Rouse, T. Ingram, R. Barnett, R. Sengupta
2025 ABS0847
RETROSPECTIVE SINGLE-CENTRE ANALYSIS OF SURVIVAL AND SAFETY SIGNALS IN AUTOIMMUNE RHEUMATIC DISEASE PATIENTS UNDERGOING LUNG TRANSPLANTATION
,
F. A. Cooles, A. Obrzut, N. Lu, R. Levy, J. A. Aviña-Zubieta, D. Lacaille
2025 ABS0866
CAN WE EXPLAIN HOW IMAGE-BASED AI MODELS COME TO THEIR MEDICAL DECISIONS IN RHEUMATIC DISEASES A LITERATURE REVIEW AND OWN CRITICAL APPRAISAL
,
J. Nicolaes, T. Hügle
2025 ABS0873
THE EFFECT OF TREATMENT ON PULMONARY FUNCTION AND SMALL AIRWAYS IN PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES AND INTERSTITIAL LUNG DISEASE: A PROSPECTIVE CASE STUDY OF A SINGLE CENTRE
,
P. Panagopoulos, L. Chatzis, E. Chatzinikita, V. E. Georgakopoulou, K. Malagari, T. Vassilakopoulos, A. Tzioufas, A. V. Goules
2025 ABS0881
A MACHINE LEARNING ALGORITHM BASED ON A 15-AUTOANTIBODY PROFILE BY A NOVEL FULLY AUTOMATED MULTIPLEXED MICROARRAY IMMUNOASSAY FOR THE DIAGNOSIS OF AUTOIMMUNE CONNECTIVE TISSUE DISEASES
,
G. Gomez, Y. Cheng, K. Nita, M. Hausmann, C. Fischer, Y. Ataman-Önal
2025 ABS0907
ASSESSMENT OF FATIGUE IN A MONOCENTRIC ITALIAN COHORT OF RHEUMATIC DISEASES (RDS) PATIENTS THROUGH VALIDATED QUESTIONNAIRES
,
G. Voltarel, L. Moschetti, M. Bondioli, C. Orlandi, E. Pazzi, J. Mora, C. Bani, M. Fredi, F. Franceschini
2025 ABS0919
TO COMPARE THE TOLERANCE OF NINTEDANIB IN PATIENTS WITH DIFFUSE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH IMMUNOMEDIATED DISEASES VERSUS PATIENTS WITH DIFFUSE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH NON-IMMUNOMEDIATEDDISEASES IN A MULTIDISCIPLINARY RHEUMATOLOGY-PNEUMOLOGY CONSULTATION
,
M. Molinari, S. Salas, L. Gómez Carrera, M. Torres Vargas, C. J. Carpio Segura, P. Mariscal Aguilar, G. Bonilla, E. De Miguel
2025 ABS0933
EVALUATION OF MITOCHONDRIAL DYSFUNCTION USING MT-ATP6 LEVELS IN ANCA-ASSOCIATED VASCULITIS AND IgG4-RELATED DISEASE
,
R. C. Kardaş, İ. Vasi, D. Yildirim, B. Kaya, R. Duran, İ. Y. Çakir, İ. Karaduman, H. Küçük, B. Göker, M. A. Öztürk, A. Erden
2025 ABS0934
SEXUAL DYSFUNCTION IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES – A CROSS-SECTIONAL STUDY
,
N. Delgado, M. Guerra, A. F. Águeda, R. Pinheiro Torres, J. Rodrigues, M. Oliveira
2025 ABS0966
SOLUBLE INTERLEUKIN 2 RECEPTOR (sIL2r) AND FERRITIN RATIO IN MACROPHAGE ACTIVATION SYNDROME
,
S. Madan, M. C B, S. Balan, P. Anthony, J. V. Sreekanth, R. G, S. Krishnan
2025 ABS0971
RISK ESTIMATION FOR SUBCLINICAL HEART FAILURE USING THE PREVENT CALCULATOR IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES
,
V. Gonzalez-Gonzalez, O. A. Garza-Flores, D. A. Galarza-Delgado, J. R. Azpiri-Lopez, I. J. Colunga-Pedraza, J. A. Cardenas-de la Garza, R. I. Arvizu-Rivera
2025 ABS0983
COMPARISON OF THE EXTENSION OF DIFFERENT TOMOGRAPHIC PATTERNS OF CONNECTIVE TISSUE DISEASE-ASSOCIATED INTERSTITIAL LUNG DISEASE AMONG DIFFERENT ANTIBODY SPECIFICITIES USING ARTIFICIAL INTELLIGENCE APPLICATION: A SINGLE-CENTER PILOT STUDY.
,
R. Barile, C. Rotondo, B. Capuano, R. Colia, V. Rella, G. Carabellese, G. Giancaspro, F. P. Cantatore, A. Corrado
2025 ABS1007
FERTILITY AND PREGNANCY OUTCOMES AFTER CAR T-CELL THERAPY: WHAT DO WE KNOW SO FAR
,
P. Kremer, M. T. Holzer, N. Ruffer, I. Kötter, M. Krusche, I. Haase
2025 ABS1032
TWO DECADES OF RHEUMATOLOGY RESEARCH (2000-2023): A DYNAMIC TOPIC MODELING PERSPECTIVE
,
A. Madrid García, D. Freites, B. Merino, I. Pérez - Sancristóbal, L. Rodriguez Rodriguez
2025 ABS1033
RHEUMATOLOGY ON REDDIT: A DESCRIPTIVE AND SENTIMENT ANALYSIS
,
A. Madrid García, B. Merino
2025 ABS1035
NATIONAL SURVEY OF IMMUNE-MEDIATED INFLAMMATORY DISEASE (IMID) PATIENTS ON VARICELLA-ZOSTER VIRUS (VZV) VACCINE ACCEPTANCE
,
T. Goulenok, M. Carvalho, A. Mageau, E. Hachulla, B. Terrier, T. Papo, K. Sacre
2025 ABS1055
GB261 (CND261), A NOVEL CD20/CD3 T-CELL ENGAGER, HAS A DIFFERENTIATED SAFETY PROFILE AND POTENTIAL FOR DEVELOPMENT IN AUTOIMMUNE DISEASES
,
Y. Song, Z. Li, L. Li, Z. Qian, K. Zhou, L. Fan, P. Tan, P. Giri, Z. Li, J. Jin, W. Liu, J. Haddon, P. Morcos, J. Lim, P. Wung, S. Inam, Y. Xie, T. Li, J. Zhu
2025 ABS1130
IMPACT OF OPHTHALMIC CONDITIONS ON HOSPITAL OUTCOMES IN PATIENTS WITH SYSTEMIC RHEUMATIC DISEASES: A NATIONWIDE STUDY
,
I. Mannstadt, Y. Wu, R. Parikh, B. Mehta
2025 ABS1156
SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY VOLUNTEERS OF VENT-03, A NOVEL cGAS INHIBITOR FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
,
D. X. Valencia, O. Spiegelstein, N. Fradet, A. Chefson, P. Cyr, K. Pike, J. Stewart, R. Beveridge
2025 ABS1158
ISOLATED ANTI-U1-RNP ANTIBODY DETECTED VIA PARTICLE-BASED MULTI-ANALYTE TECHNOLOGY (PMAT): CORRELATION OF TITRE INTENSITY WITH CONNECTIVE TISSUE DISEASES
,
L. Gabrie, M. Garcia, H. M. Ulloa-Alvarado, J. Irure-Ventura, D. Prieto-Peña, R. Blanco, M. López Hoyos
[1]
Adherence in the transition from pediatric to adult care
2025
2025 OP0242
UNMET NEEDS OF ADOLESCENTS AND YOUNG ADULTS WITH JUVENILE IDIOPATHIC ARTHRITIS: A SYSTEMATIC REVIEW
,
S. Hecquet, M. Jouret, M. Thomas, A. Combier, J. Wipff, G. Touanga, A. Lohse, A. belot, J. P. Larbre, V. Hentgen, M. Hofer, P. Quartier, A. Loisel, H. Lefevre, Y. Allanore
[1]
All about Paget's Disease: from pathophysiology to diagnosis and treatment
2025
2025 OP0124
ZNF687 REGULATES OSTEOCLASTOGENESIS AND DRIVES PAGET’S DISEASE OF BONE THROUGH MYELOID LINEAGE POPULATIONS
,
S. Russo, F. Gianfrancesco
[12]
Antiphospholipid syndrome
2025
2025 ABS0022
LUPUS ANTICOAGULANT: PERFORMANCE EVALUATION OF DUAL REAGENT SCREENING ASSAYS
,
N. Jaballah, I. Ghachem, M. Y. Kaabar, H. Khemiri, A. Bachali, S. Wafa, R. Amri, H. Tounsi
2025 ABS0029
MULTIPLEX IMMUNOPHENOTYPING OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME OR SEROPOSITIVITY WITHOUT CLINICAL SYMPTOMES
,
A. Balog, B. Kari, E. Korogány, N. Gémes, D. G. Honfi, N. Cselei, G. Szebeni
2025 ABS0043
CLINICAL-IMMUNOLOGICAL PROFILING AND PREDICTORS OF THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: DATA FROM A DEDICATED CLINIC AT A TERTIARY CENTRE
,
A. R. Lopes, F. Costa, A. Teodósio Chícharo, A. M. Duarte Monteiro, P. Gaspar, V. C Romão, A. R. Cruz-Machado
2025 ABS0099
IgA Subclasses in APS: A Novel Perspective on Antigen Specificity and Clinical Impact
,
E. Tj, M. R. Shipa, M. Ehrenstein, T. McDonnell, D. McCluskey
2025 ABS0236
VARIABLES ASSOCIATED WITH RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AT A SOUTH AMERICAN HOSPITAL
,
J. Hernandez, L. A. Dulcey Sarmiento, J. Gomez Ayala, V. Ochoa Castellanos, J. S. Theran Leon, V. Navas
2025 ABS0292
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME: CLINICAL CHARACTERISTICS AND OUTCOMES. FIVE-YEAR EXPERIENCE
,
R. Jimenez-Soto, J. Merayo-Chalico, M. Martínez-Ruíz, M. Espinosa Leon, J. E. Said-Diego, M. D. C. Zamora-Medina, G. Guaracha-Basáñez
2025 ABS0377
COMPARATIVE EVALUATION OF THE PERFORMANCE OF REVISED SAPPORO AND 2023 ACR/EULAR CLASSIFICATION CRITERIA IN PAEDIATRIC ONSET ANTIPHOSPHOLIPID SYNDROME - A SINGLE CENTRE COHORT WITH LONG-TERM FOLLOW-UP
,
S. Hussain, H. Bradford, T. McDonnell, C. Ciurtin
2025 ABS0518
A COMPARATIVE ANALYSIS OF PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME IN A GREEK COHORT: EVALUATING PATIENTS WITH DIVERSE THROMBOTIC PHENOTYPES
,
V. Lainis, M. Krikelis, O. Katsouli, P. G. Vlachoyiannopoulos
2025 ABS0608
IMPACT OF THE NEW 2023 ACR/EULAR CLASSIFICATION CRITERIA FOR ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH RETINAL VEIN OCCLUSION
,
R. Gálvez-Sánchez, Z. Salmón-García, M. Fernandez Garcia, A. Verceró Varona, B. Gonzalez Mesones, V. Martinez Taboada, J. L. Hernández
2025 ABS0914
ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN PEDIATRIC LUPUS FROM NORTH-WEST INDIA: CLINICO-LABORATORY FEATURES AND APPLICATION OF 2023 ACR/EULAR CRITERIA
,
A. Thangaraj, R. Kumar Pilania, S. Sharma, N. Kumar, M. Dhaliwal, A. Kumar Jindal, P. Vignesh, D. Suri, A. Rawat, J. Ahluwalia, S. Singh
2025 ABS0928
VASCULAR LIVER DISORDERS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A NATIONAL RETROSPECTIVE MULTICENTRE STUDY
,
M. Katims, M. Pineton de Chambrun, C. Yelnik, Z. Amoura, M. Lambert, T. Papo, P. E. Rautou, N. Costedoat-Chalumeau, K. Sacre
2025 ABS1092
OLDER PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME PRESENTING WITH ARTERIAL THROMBOSIS ARE AT RISK TO DEVELOP SMALL VESSEL INVOLVEMENT
,
A. Teodósio Chícharo, A. R. Lopes, F. Costa, A. M. Monteiro, P. Gaspar, V. C Romão, A. R. Cruz-Machado
[25]
Autoinflammatory disease, Vexas and other monogenic diseases
2025
2025 ABS0057
EXPLORING THE CELLULAR AND MOLECULAR MECHANISMS OF IL-1Β PRODUCTION DIRECTED BY T CELLS FOR TREATING T CELL-MEDIATED AUTOIMMUNE DISEASES
,
J. Zhao, Z. Liang, B. Kessler, L. Chen
2025 ABS0065
CLINICAL AND EVOLUTIONARY CHARACTERISATION OF PATIENTS WITH STILL’S DISEASE: ANALYSIS BASED ON EULAR/PRES 2024 RECOMMENDATIONS
,
L. Álvarez Ortiz, J. Manzaneque Sánchez, L. Mendez Diaz, C. Aguilera Cros
2025 ABS0121
CLINICAL FEATURES IN VEXAS SYNDROME: A SYSTEMATIC REVIEW
,
A. Al-Hakim, S. Goldberg, S. Gaillard, M. Heiblig, D. B. Beck, S. Savic
2025 ABS0158
THE ASSESSMENT OF IL-15 IN PATIENTS WITH STILL’S DISEASE, IN VITRO AND EX-VIVO FINDINGS
,
I. Di Cola, M. Vomero, C. Castellini, O. Berardiucrti, M. Breccia, L. Navarini, P. Cipriani, R. Giacomelli, P. Ruscitti
2025 ABS0238
VALIDATION OF CLASI AND R-CLASI IN PATIENTS WITH SLE AT A SOUTH AMERICAN HOSPITAL
,
J. Hernandez, L. A. Dulcey Sarmiento, J. Gomez Ayala, J. S. Theran Leon, V. Navas
2025 ABS0241
INTERFERON AND B CELL SUBPOPULATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AT A SOUTH AMERICAN HOSPITAL
,
L. A. Dulcey Sarmiento, J. Hernandez
2025 ABS0244
INCREASED Tph CELLS CONTRIBUTE TO THE PATHOPHYSIOLOGY OF LATE-ONSET ADULT STILL’S DISEASE
,
M. Fukuchi, S. Takanashi, K. Tanaka, H. Tamai, Y. Kondo, N. Seki, K. Chiba, K. Yoshimoto, Y. Kaneko
2025 ABS0247
HUMAN PRIMARY MONOCYTES CELL DEATH AND IL-1ß PRODUCTION IS DIFFERENTLY REGULATED IN FMF PATIENTS COMPARED TO HEALTHY CONTROLS
,
C. R. E. Kievit, C. I. van der Made, C. M. Mulders-Manders, F. L. van de Veerdonk
2025 ABS0439
PATH TO DIAGNOSIS IN FAMILIAL MEDITERRANEAN FEVER (FMF)
,
S. Karup, F. N. Azman, D. Polat, E. Dincsoy, M. E. Cokrak, E. Berkiten, S. Ugurlu
2025 ABS0442
EVALUATION OF COMORBIDITY AND ASSOCIATED FACTORS IN FAMILIAL MEDITERRANEAN FEVER
,
N. F. Ok, H. H. Gezer, M. T. Duruöz
2025 ABS0445
EVALUATION OF MEDICATION ADHERENCE OF FMF PATIENTS TRANSITIONED FROM A PEDIATRIC CLINIC TO AN ADULT CLINIC: A CROSS-SECTIONAL STUDY
,
F. Z. Avci, F. N. Azman, E. S. Unsal, S. Ugurlu
2025 ABS0459
TO ASSESS THE CARDIOVASCULAR RISK AND THE COLCHICINE’S EFFECT IN FAMILIAL MEDITERRANEAN FEVER
,
M. T. Duruöz, N. F. Ok, H. H. Gezer
2025 ABS0479
RECOGNITION OF ADULT-ONSET STILL’S DISEASE IN PATIENTS PRESENTING WITH FEVER OF UNKNOWN ORIGIN IN THE INTERNAL MEDICINE WARD: PRELIMINARY FINDINGS FROM THE PROSPECTIVE EVALUATION OF THE HACETTEPE FUO ALGORITHM
,
B. Firlatan Yazgan, G. S. Kart Bayram, B. Bulat, M. Ekici, E. Unaldi, E. Bilgin, L. Kiliç, U. Kalyoncu
2025 ABS0521
MUSCULOSKELETAL ULTRASOUND IN PATIENTS WITH ADULT STILL’S DISEASE; TENDON INVOLVEMENTS PREDICT RELAPSE
,
K. Furuhashi, Y. Kondo, K. Hiramoto, H. Tamai, C. Takahashi, Y. Inoue, Y. Kaneko
2025 ABS0579
Validation of sJADAS in adult patients with Still’s disease
,
G. S. Moysidou, S. Katechis, B. Fautrel, S. Mitrovic
2025 ABS0657
INSIGHTS FROM A ONE-YEAR INTERNATIONAL MONTHLY QUIZ ON AA AMYLOIDOSIS CAUSES: ENGAGING 2,597 VOTERS ACROSS FRENCH-SPEAKING COUNTRIES
,
R. Bourguiba, W. Ammouri, C. Jurcut, E. Dagher, B. M. Nassani, G. Khellaf, C. Catalano, J. Laouni, M. Delafosse, L. Berchtold, S. Ndongo, S. Ducharme-Benard, F. Said, S. Georgin-Lavialle
2025 ABS0742
VEXINATIONS: A MULTICENTER RETROSPECTIVE STUDY ON VACCINATIONS IN VEXAS SYNDROME
,
C. Campochiaro, C. Piccolo, E. Diral, G. Bergonzi, A. Tomelleri, C. Gurnari, S. Bindoli, L. Iorio, I. Guidea, P. Sfriso, M. Cuccaro, K. Pathmanathan, L. Host, S. Ali, E. Morsia, L. Vago, F. Ciceri, L. Dagna
2025 ABS0766
POPULATION GENETIC STUDY OF YAO SYNDROME
,
S. Wu, Z. Deng, A. Uddin, B. Xin, P. Gorevic, Q. Yao
2025 ABS0783
DIAGNOSTIC DELAY IN SYSTEMIC AUTOINFLAMMATORY DISEASE: PRELIMINARY RESULTS FROM THE EUROFEVER REGISTRY
,
D. Piskin, M. Romano, N. Zitoun, R. Caorsi, Y. H. Choi, M. Gattorno, E. Demirkaya
2025 ABS0807
REAL-WORLD INSIGHTS ON TREATMENT PATTERNS, SAFETY, AND EFFICACY OF CANAKINUMAB IN ADULT PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF)
,
B. Firlatan Yazgan, G. S. Kart Bayram, B. Bulat, L. Kiliç, U. Kalyoncu, Ş. A. Bilgen, A. I. Ertenli, O. Karadag
2025 ABS0859
AZACITIDINE REDUCES SYMPTOMS AND UBA1 MUTATION VARIANT ALLELE FREQUENCY IN PATIENTS WITH VEXAS SYNDROME: A RETROSPECTIVE COHORT STUDY
,
S. Wijnberger, M. Natzijl, J. Weering, J. Meerlo, J. Salzbrunn, A. Mulder, S. Klein, A. Rutgers
2025 ABS0921
FACTORS TRIGGERING ATTACKS AND COPING STRATEGIES IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
,
E. B. Ata, H. İ. Y. Atli, M. Sungur Özgünen, E. Karacali, F. M. Dogan, E. Tekgoz, S. Yurumez Colak, S. Yilmaz, M. Çinar
2025 ABS0973
GENETICS, CLINICAL CHARACTERISTICS, AND MANAGEMENT OF FAMILIAL MEDITERRANEAN FEVER IN DIVERSE POPULATIONS: A COMPARATIVE STUDY OF BARI AND ISTANBUL
,
N. Jaber, B. Kilic, L. Yagci, A. Ozturk, M. Khalil, A. Stella, A. Di Ciaula, S. Ugurlu, P. Portincasa
2025 ABS0982
SYSTEMIC JIA-ASSOCIATED LUNG DISEASE: A MULTICENTER ANALYSIS OF CLINICAL FEATURES,TREATMENT CHALLENGES AND OUTCOMES
,
D. Unal, V. Cam, E. Kilic Konte, E. Çelikel, S. Ozdel, M. K. Gurgoze, E. Sag, Ö. Basaran, K. Barut, Y. Bilginer, O. Kasapcopur, S. Ozen
2025 ABS1133
INDICATIONS, EFFICACY, AND SAFETY OF CANAKINUMAB: REAL LIFE EXPERIENCE OF A TERTIARY RHEUMATOLOGY CLINIC
,
R. Deniz, O. Altun, S. Karabulut Gök, C. Tansu Yavuz, H. K. Yerişenoğlu Demir, F. Deniz, R. Mirza Altintaş, K. Uğur, A. E. Boncukcuoğlu, B. Karaalioglu, G. Akkuzu, D. S. Ozgur, F. Yildirim, C. Erzik, C. Bes
[8]
Basic Abstract Sessions: A Crystal Clear understanding of Gout and CPPD
2025
2025 OP0125
TARGETING NLRP3 INFLAMMASOME ACTIVATION AND INFLAMMATION IN GOUT WITH NEK7 MOLECULAR GLUE DEGRADERS: A NOVEL THERAPEUTIC STRATEGY
,
D. Wible, Q. Chen, S. Nguyen, M. Schillo, V. Verdine, K. Gosala, A. Trouilloud, H. Farine, V. Strande, D. Bonenfant, C. King, K. Meier, C. Komishane, M. Cabanski, A. Kostikova, L. McAllister, E. Krishnan, F. Janku, M. Walter, E. Liardo, A. Paterson, A. Iracheta-Vellve
2025 OP0126
IDENTIFICATION OF METABOLITE PROFILES DURING GOUT FLARE IN A PROSPECTIVE GOUT COHORT: GLUTAMINE AND HISTIDINE AS ANTI-INFLAMMATORY METABOLITES
,
C. Leroy, N. Pham, C. Caradeuc, A. L. Nguyen, F. Brial, B. Kischkel, G. Jayat, N. Giraud, F. Fenaille, L. Joosten, A. Latourte, P. Richette, F. Castelli, G. Bertho, H. K. Ea
2025 OP0127
DEVELOPMENT OF ALLOSTERIC ACTIVATORS OF CYSTATHIONINE G LYASE (CSE) TO AUGMENT HYDROGEN SULFIDE (H2S) AND INHIBIT PATHOLOGIC CARTILAGE CALCIFICATION
,
D. Ehirchiou, S. Nasi, V. Chobaz, R. Riedl, S. Germann, A. Brandenberger, E. Bommeli, C. Blatter, G. Cirino, A. So, N. Busso
2025 OP0128
A PROTEOMIC ANALYSIS OF SUBCLINICAL SYNOVIAL INFLAMMATION ASSOCIATED WITH MONOSODIUM URATE CRYSTAL DEPOSITION
,
M. Andrés, M. L. Peral-Garrido, S. Ortuño, R. Caño, S. Gómez, A. Bermúdez-García, T. Lozano, M. Perdiguero, E. Caro-Martínez, R. Sanchez-Ortiga, C. Ruiz-García, R. Francés
2025 OP0129
INTRACELLULAR FATES OF MONOSODIUM URATE AND CALCIUM PYROPHOSPHATE CRYSTALS IN MACROPHAGES AND THEIR DISSOLUTION
,
C. Leroy, N. Pham, F. Brial, B. Kischkel, G. Jayat, E. Ishow, C. Combes, L. Joosten, A. Latourte, P. Richette, H. K. Ea
2025 OP0130
EXPERIMENTAL STUDY OF TARGETING PAD4 TO INHIBIT THE FORMATION OF NEUTROPHIL EXTRACELLULAR TRAP NETWORK FOR THE TREATMENT OF GOUT
,
Y. Wang, D. Man, H. Li
2025 OP0131
MULTITARGETED BIOLOGICAL ACTIONS OF POLYDATIN IN PREVENTING PSEUDOGOUT ACUTE ATTACK
,
C. Baggio, P. Galozzi, A. C. Damasco, V. Lazzarin, G. Ravagnan, P. Sfriso, R. Ramonda, L. Punzi, G. Pennelli, A. Doria, R. Luisetto, F. Oliviero
2025 OP0132
POSITIVE ALLOSTERIC MODULATORS (PAMS) OF CYSTATHIONINE GAMMA LYASE (CSE) INCREASE HYDROGEN SULFIDE (H2S) AND INHIBIT NLRP3 ACTIVATION
,
D. Ehirchiou, T. Chirayath, S. Nasi, V. Chobaz, R. Riedl, C. Blatter, S. Germann, A. Brandenberger, E. Bommeli, N. Busso, A. So
[8]
Basic Abstract Sessions: Big data and small molecules - Novel rheumatoid arthritis mechanisms
2025
2025 OP0243
SINGLE-CELL RNA SEQUENCING OF ACPA-ENRICHED B CELLS REVEALED A CD11c+ ATYPICAL B CELL GENE SIGNATURE IN RHEUMATOID ARTHRITIS
,
Y. Nagafuchi, L. Slot, D. Simaite, A. M. Bakker, T. Andreani, E. B. van den Akker, T. Huizinga, C. Struebing, R. E. M. Toes, H. U. Scherer
2025 OP0244
INTEGRATIVE MULTI-OMICS PHENOTYPING IN BLOOD REVEALS DISTINCT IMMUNE AND METABOLIC SIGNATURES BETWEEN ACPA-NEGATIVE AND ACPA-POSITIVE RHEUMATOID ARTHRITIS
,
J. Sung, B. Hur, V. Gupta, M. Oh, H. Zeng, C. S. Crowson, K. J. Warrington, E. Myasoedova, V. L. Kronzer, J. M.III Davis
2025 OP0245
C3a-C3aR1-MEDIATED INTERACTIONS BETWEEN FIBROBLAST-LIKE SYNOVIOCYTES AND MACROPHAGES PROMOTE THE PROGRESSION OF RHEUMATOID ARTHRITIS
,
M. Cai, Z. Chen
2025 OP0246
SYNOVIAL TISSUE ENRICHMENT OF OXYLIPINS AND THEIR MEDIATORS PROVIDES INSIGHT INTO REMISSION MAINTENANCE IN RHEUMATOID ARTHRITIS
,
S. Perniola, J. Murillo-Saich, D. Somma, C. Di Mario, B. Tolusso, D. Campobasso, M. Gessi, L. Petricca, M. R. Gigante, V. A. Pacucci, D. Bruno, M. M. Lizzio, E. Gremese, M. A. D’Agostino, M. Kurowska-Stolarska, M. Guma, S. Alivernini
2025 OP0247
SINGLE CELL IMMUNOPROFILE OF SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS WITH TNF-α/JAK INHIBITOR TREATMENT
,
C. He, X. Xia, Z. Xue, G. Yin, H. Xu, Q. Xie
2025 OP0248
CELLULAR AND MOLECULAR DECONSTRUCTION OF (TENO)SYNOVIAL TISSUE ACROSS DIFFERENT RHEUMATOID ARTHRITIS PHASES AND COMPARISON WITH ADJACENT SYNOVIUM
,
L. A. Coletto, D. Somma, C. Di Mario, D. Campobasso, B. Tolusso, P. Rizzuti, D. Bruno, C. Tur, P. Rubortone, B. Fresch, T. Hubert, N. Goulas, L. Petricca, M. R. Gigante, V. A. Pacucci, S. Perniola, A. Elmesmari, L. MacDonald, R. Benvenuto, M. Gessi, E. Gremese, M. A. D’ Agostino, M. M. Lizzio, M. Kurowska-Stolarska, S. Alivernini
2025 OP0249
SITE-SPECIFIC MORPHOLOGY AND FUNCTION OF PRIMARY CILIA IN SYNOVIAL FIBROBLASTS FROM DIFFERENT JOINT LOCATIONS
,
M. Mirrahimi, A. Khmelevskaya, M. Houtman, C. Geiss, C. Ospelt
2025 OP0250
COMPREHENSIVE IMMUNOPHENOTYPING REVEALS OLIGOCLONAL EXPANSION OF AUTOREACTIVE T CELLS AND THE ROLE OF IL-6 IN THEIR DIFFERENTIATION IN RHEUMATOID ARTHRITIS
,
S. Kubo, K. Kusaka, Y. FUJITA, N. Takahiro, Y. Miyazaki, K. Ishigaki, M. Kono, H. Tanaka, H. Sakai, M. Ueno, Y. Todoroki, Y. Satoh-Kanda, I. Miyagawa, S. Nakayamada, Y. Tanaka
Goto page:
10
50
100
